Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-21-050399

Chief Medical Officer acquired 40,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Deliargyris Efthymios · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-04-12 Grant or award : show line 1 in the form +40,000 $8.99 $359,600 183,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-12 Grant or award : show line 2 in the form Stock Option (right to buy) +63,250 63,250 D
Loading xslF345X03/tm2113016d5_4.xml…